Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thilo Hackert

Showing results (531-540 of 631) with videos related to

Pageof 64
Sort By:
Nature Medicine|February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaElisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
Molecular Cancer|November 14, 2023
Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysisNikolas H Stoecklein, Georg Fluegen, Rosa Guglielmi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 9, 2025
Global survey on surgeon preference and current practice for pancreatic neck and body cancer with portomesenteric venous involvementHiroyuki Ishida, Thomas F Stoop, Atsushi Oba, et al.
Translational Oncology|September 1, 2024
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic responseJingyu An, Roma Kurilov, Teresa Peccerella, et al.
Cancer Medicine|November 13, 2024
Prevalence and Significance of AGR2 Expression in Human CancerNina Schraps, Jacob Constantin Port, Anne Menz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 3, 2017
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA ConsortiumDaniele Campa, Ofure Obazee, Manuela Pastore, et al.
Surgery|March 27, 2023
The PD-ROBOSCORE: A difficulty score for robotic pancreatoduodenectomyNiccolò Napoli, Concetta Cacace, Emanuele F Kauffmann, et al.
Annals of Surgery|March 21, 2025
Personalized Surveillance Intervals for Intraductal Papillary Mucinous Neoplasm (IPMN): Multicenter Study Using Parametric ModelsClaudio Ricci, Stefano Crippa, Johnathan Hee, et al.
Lancet (London, England)|September 14, 2017
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trialMarkus K Diener, Felix J Hüttner, Meinhard Kieser, et al.
Cancer Medicine|March 13, 2026
Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 TumorsNina Schraps, Anne Menz, Florian Viehweger, et al.
Pageof 64

Showing results (531-540 of 631) with videos related to

Sort By:
Pageof 64
Nature Medicine|February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaElisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
Molecular Cancer|November 14, 2023
Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysisNikolas H Stoecklein, Georg Fluegen, Rosa Guglielmi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 9, 2025
Global survey on surgeon preference and current practice for pancreatic neck and body cancer with portomesenteric venous involvementHiroyuki Ishida, Thomas F Stoop, Atsushi Oba, et al.
Translational Oncology|September 1, 2024
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic responseJingyu An, Roma Kurilov, Teresa Peccerella, et al.
Cancer Medicine|November 13, 2024
Prevalence and Significance of AGR2 Expression in Human CancerNina Schraps, Jacob Constantin Port, Anne Menz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 3, 2017
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA ConsortiumDaniele Campa, Ofure Obazee, Manuela Pastore, et al.
Surgery|March 27, 2023
The PD-ROBOSCORE: A difficulty score for robotic pancreatoduodenectomyNiccolò Napoli, Concetta Cacace, Emanuele F Kauffmann, et al.
Annals of Surgery|March 21, 2025
Personalized Surveillance Intervals for Intraductal Papillary Mucinous Neoplasm (IPMN): Multicenter Study Using Parametric ModelsClaudio Ricci, Stefano Crippa, Johnathan Hee, et al.
Lancet (London, England)|September 14, 2017
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trialMarkus K Diener, Felix J Hüttner, Meinhard Kieser, et al.
Cancer Medicine|March 13, 2026
Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 TumorsNina Schraps, Anne Menz, Florian Viehweger, et al.
Pageof 64